Antibacterial R&D at a Crossroads: We've Pushed as Hard as We Can... Now We Need to Start Pulling! COMMENT

CLINICAL INFECTIOUS DISEASES

卷 73, 期 11, 页码 E4451-E4453

OXFORD UNIV PRESS INC

antibacterial agents; antibiotic resistance; antibiotic innovation; FDA

Immunology Infectious Diseases Microbiology

1. Social Innovation in Drug Resistance Program at Boston University
2. School of Law, both at Boston University